Effect of streptozotocin on the glutathione S-transferases of mouse liver cytosol.
Streptozotocin (STZ) increased the activity of mouse hepatic glutathione (GSH) S-transferases assayed with 1-chloro-2,4-dinitrobenzene. Nicotinamide administered prior to STZ prevented the hyperglycemia indicative of STZ-induced diabetes, but had no effect on the increase in GSH S-transferase activity caused by the drug. Another diabetogenic agent, alloxan, did not alter GSH S-transferase activity. Thus, streptozotocin may be increasing GSH S-transferase activity directly, and not as a result of the diabetic state the drug induces. Two transferases were characterized from mouse liver cytosol. One was a homodimer with a subunit molecular weight of about 28,000 and a pI of about 8.2. The other was also a homodimer with a subunit molecular weight of about 27,500 and a pI of about 9.2. The pI 8.2 GSH S-transferase was induced by STZ, while the pI 9.2 transferase was decreased by the drug. At least one other transferase appeared to be induced by STZ. Two other nitroso compounds, chlorozotocin and diethylnitrosamine, also increased GSH S-transferase activity, suggesting that this effect may be nitroso related.
Agius
C
C
Gidari
A S
AS
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D003600:Cytosol / Q000201:enzymology*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D005982:Glutathione Transferase / Q000032:analysis*; D007525:Isoelectric Focusing; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D051379:Mice; D008970:Molecular Weight; D009536:Niacinamide / Q000494:pharmacology; D013311:Streptozocin / Q000494:pharmacology*
D000970:Antineoplastic Agents; D009536:Niacinamide; D013311:Streptozocin; D005982:Glutathione Transferase